Your browser doesn't support javascript.
loading
Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia.
Abedin, Sameem M; Badar, Talha; Gauger, Katelyn; Michaelis, Laura C; Runaas, Lyndsey; Carlson, Karen-Sue; Murthy, Gs Guru; Atallah, Ehab.
Afiliação
  • Abedin SM; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States. Electronic address: sabedin@mcw.edu.
  • Badar T; Division of Hematology and Oncology, Mayo Clinic Jacksonville, Jacksonville, FL, United States.
  • Gauger K; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Michaelis LC; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Runaas L; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Carlson KS; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Murthy GG; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Atallah E; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Leuk Res ; 123: 106984, 2022 12.
Article em En | MEDLINE | ID: mdl-36401944

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Leucemia Mieloide Aguda Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article